Allermi – a direct-to-consumer telehealth service providing a customized approach to allergy relief – announced a $3.5 million seed round to deliver a personalized solution to allergy care. This funding round was led by Nelstone Ventures, who twice funded Apostrophe – a direct-to-consumer telehealth service providing customized skincare solutions – and helped lead its nine-figure sale to Hims & Hers. Along with Nelstone Ventures, FourSight Capital Partners also participated in the round, FINSMES reports.
Allermi raised a $1 million pre-seed round in September.
Allermi was co-founded by Dr. Robert Bocian, an allergist for more than 30 years and associate professor of allergy-immunology at Stanford. Read more.
